NCT02763540

Brief Summary

Pathological comparisons of surgical open lung biopsies and cryobiopsies in non-IPF ILD. Patients with non-IPF ILD eligible for an open lung biopsy will undergo cryobiopsy in the same time. Between observers agreement will be assessed for each pairs of samples.

Trial Health

90
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jan 2016

Typical duration for not_applicable

Geographic Reach
2 countries

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 20, 2016

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 13, 2016

Completed
22 days until next milestone

First Posted

Study publicly available on registry

May 5, 2016

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 25, 2018

Completed
Last Updated

March 19, 2021

Status Verified

March 1, 2021

Enrollment Period

2.2 years

First QC Date

April 13, 2016

Last Update Submit

March 16, 2021

Conditions

Keywords

ILDPathologydiagnosislung biopsy

Outcome Measures

Primary Outcomes (1)

  • The percentage of concordant diagnoses between cryobiopsy and surgical lung biopsy.

    The gold standard is the consensual diagnosis between the two readers established from surgical biopsy

    for statistical analysis, 12 months after the first inclusion

Secondary Outcomes (5)

  • The percentage homology between diagnosis obtained by surgical biopsy and cryobiopsy with the multidisciplinary approach

    one day after inclusion

  • The percentage homology intra and inter observer for histopathological analysis of each type of sample by Mac Nemar test

    for statistical analysis, 12 months after the first inclusion

  • The number of elementary lesions actually present in the two samples for the same patient

    One day after inclusion

  • The time of the gesture and the respective anesthetic complexities of each procedure

    One day after inclusion

  • The rate of adverse events

    for statistical analysis, 12 months after the first inclusion

Study Arms (1)

Lung cryobiopsy

OTHER
Procedure: Lung cryobiopsy

Interventions

Transbronchial cryobiopsy

Also known as: Per endoscopy
Lung cryobiopsy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Non IPF ILD eligible for surgical lung biopsy reviewed during multidisciplinary approach

You may not qualify if:

  • Ineligible for lung biopsy: pulmonary hypertension, coagulation deficiency, FEV\<11, giant emphysematous bullae, hemodynamic instability severe hypoxia, general anesthetic ineligibility

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Arnaud de Villeneuve University Hospital

Montpellier, 34295, France

Location

S'Orsola-Malpighi hospital

Bologna, 40138, Italy

Location

Related Publications (6)

  • Romagnoli M, Colby TV, Suehs CM, Vachier I, Molinari N, Bourdin A. Cryobiopsy Compared with Surgical Lung Biopsy in ILD: Reply to Maldonado et al., Froidure et al., Bendstrup et al., Agarwal et al., Richeldi et al., Rajchgot et al., and Quadrelli et al. Am J Respir Crit Care Med. 2019 Oct 1;200(7):944-946. doi: 10.1164/rccm.201906-1252LE. No abstract available.

    PMID: 31442081BACKGROUND
  • Bourdin A, Suehs CM, Colby TV, Vachier I, Molinari N, Romagnoli M. Reply to Wand et al.: Role of Transbronchial Cryobiopsy in Interstitial Lung Diseases: An Ongoing Tale. Am J Respir Crit Care Med. 2020 Jan 15;201(2):260-261. doi: 10.1164/rccm.201909-1736LE. No abstract available.

    PMID: 31535900BACKGROUND
  • Bourdin A, Romagnoli M, Gamez AS, Hireche K, Berthet JP, Mallet JP, Vachier I, Nava S, Reynaud P, Molinari N, Suehs C. Careful consideration of the bleeding caused by transbronchial lung cryobiopsies. Eur Respir J. 2020 May 21;55(5):1902415. doi: 10.1183/13993003.02415-2019. Print 2020 May. No abstract available.

    PMID: 32439734BACKGROUND
  • Romagnoli M, Colby TV, Berthet JP, Gamez AS, Mallet JP, Serre I, Cancellieri A, Cavazza A, Solovei L, Dell'Amore A, Dolci G, Guerrieri A, Reynaud P, Bommart S, Zompatori M, Dalpiaz G, Nava S, Trisolini R, Suehs CM, Vachier I, Molinari N, Bourdin A. Poor Concordance between Sequential Transbronchial Lung Cryobiopsy and Surgical Lung Biopsy in the Diagnosis of Diffuse Interstitial Lung Diseases. Am J Respir Crit Care Med. 2019 May 15;199(10):1249-1256. doi: 10.1164/rccm.201810-1947OC.

  • Suehs C, Bourdin A, Vachier I, Molinari N, Romagnoli M. Transbronchial cryobiopsy in the diagnosis of interstitial lung diseases: methodologies and perspectives from the Cryo-PID and COLDICE studies. Ann Transl Med. 2020 Oct;8(20):1330. doi: 10.21037/atm-20-2814. No abstract available.

  • Reynaud P, Ahmed E, Serre I, Knabe L, Bommart S, Suehs C, Vachier I, Berthet JP, Romagnoli M, Vernisse C, Mallet JP, Gamez AS, Bourdin A. Club Cell Loss as a Feature of Bronchiolization in ILD. Front Immunol. 2021 Feb 26;12:630096. doi: 10.3389/fimmu.2021.630096. eCollection 2021.

MeSH Terms

Conditions

Lung Diseases, InterstitialDisease

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Arnaud Bourdin, MD, PhD

    University Hospitals of Montpellier

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 13, 2016

First Posted

May 5, 2016

Study Start

January 20, 2016

Primary Completion

March 30, 2018

Study Completion

June 25, 2018

Last Updated

March 19, 2021

Record last verified: 2021-03

Locations